Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pretax income is the income that a company earns before paying income taxes. Plandai Biotechnology's pretax income for the
six
months ended in Jun. 2023 was $-19.80 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Jun. 2023 was $-19.80 Mil.
Plandai Biotechnology's pretax margin was %.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Plandai Biotechnology Pre-Tax Income Related Terms
Plandai Biotechnology Pre-Tax Income Historical Data
* Premium members only.
The historical data trend for Plandai Biotechnology's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PLPL vs CRGH, TCRI, MAYX: Pre-Tax Income Comparison
For the Specialty Business Services subindustry, Plandai Biotechnology's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Plandai Biotechnology Pre-Tax Income vs Business Services Industry
For the Business Services industry and Industrials sector, Plandai Biotechnology's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Plandai Biotechnology's Pre-Tax Income falls into.
For stock reported annually, GuruFocus uses latest annual data as the TTM data. Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2023 was $-19.80 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Plandai Biotechnology (PLPL) has a Pre-Tax Income of $-19.80 Mil as of Jun. 2023. Pre-Tax Income is the total earnings before taxes but after all operating and interest expenses. View historical data on Plandai Biotechnology and its competitors.
Is Plandai Biotechnology's Pre-Tax Income too high?
Plandai Biotechnology's current Pre-Tax Income is $-19.80 Mil.
How does Plandai Biotechnology's Pre-Tax Income compare to CRGH and TCRI?
Plandai Biotechnology's Pre-Tax Income of $-19.80 Mil can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pre-Tax Income for a Business Services company?
A good Pre-Tax Income depends on the Business Services industry context. However, Pre-Tax Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pre-Tax Income mean?
A high Pre-Tax Income can signal that a stock is expensive relative to its fundamentals. Pre-Tax Income is the total earnings before taxes but after all operating and interest expenses. View historical data on Plandai Biotechnology and its competitors. Plandai Biotechnology's current Pre-Tax Income is $-19.80 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Plandai Biotechnology stock overvalued right now?
Plandai Biotechnology (PLPL) has a current Pre-Tax Income of $-19.80 Mil. The current Pre-Tax Income is $-19.80 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pre-Tax Income calculated?
Pre-Tax Income is calculated from a company's financial statements. For Plandai Biotechnology (PLPL), the current Pre-Tax Income is $-19.80 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PLPL has been successfully added to your 
